Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia
Copyright policy )Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is the most common human leukemia, and dysregulation of tRNA-derived short noncoding RNA (tsRNA) (tRF-1) expression is an accompanying event in the development of this disease. tsRNAs are fragments originating from the 3′ end of tRNA precursors and do not contain mature tRNA sequences. In contrast to tsRNAs, mature tRFs (tRF-3s, tRF-5s, and internal tRFs) are produced from mature tRNA sequences and are redundant fragments. We investigated tsRNA expression in CLL and determined tsRNA signatures in indolent CLL and aggressive CLL vs. normal B cells. We noticed that both ts-43 and ts-44 are derived from distinct genes of pre-tRNA His , and are down-regulated in CLL 3- to 5-fold vs. normal B cells. Thus, we investigated expression levels of tRF-5 fragments from tRNA His in CLL samples and healthy controls, and determined that such fragments are down-regulated by 5-fold in CLLs vs. normal controls. Given these results, we investigated the expression of all mature tRFs in CLLs vs. normal controls. We found a drastic dysregulation of the expression of mature tRFs in CLL. In aggressive CLL, for the top 15 up-regulated fragments, linear fold change varied from 2,053- to 622-fold. For the top 15 down-regulated fragments in CLL, linear fold change varied from 314- to 52-fold. In addition, 964 mature tRFs were up-regulated at least 2-fold in CLL, while 701 fragments were down-regulated at least 2-fold. Similar results were obtained for indolent CLL. Our results suggest that mature tRFs may have oncogenic and/or tumor suppressor function in CLL.
- University of California, San Diego United States
- University of California, San Diego United States
- University of California, San Francisco United States
- The Ohio State University United States
Lymphatic Research, Lymphoma, Oncology and Carcinogenesis, 610, Down-Regulation, RNA, Transfer, His, Rare Diseases, tsRNAs, tRFs, RNA, Transfer, Genetics, RNA Precursors, 2.1 Biological and endogenous factors, Humans, Chronic, Cancer, Leukemic, Leukemia, Biomedical and Clinical Sciences, Gene Expression Regulation, Leukemic, B-Cell, Hematology, Biological Sciences, DNA Methylation, His, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphocytic, Transfer, Small Untranslated, Gene Expression Regulation, Case-Control Studies, RNA, RNA, Small Untranslated, tRNA fragments
Lymphatic Research, Lymphoma, Oncology and Carcinogenesis, 610, Down-Regulation, RNA, Transfer, His, Rare Diseases, tsRNAs, tRFs, RNA, Transfer, Genetics, RNA Precursors, 2.1 Biological and endogenous factors, Humans, Chronic, Cancer, Leukemic, Leukemia, Biomedical and Clinical Sciences, Gene Expression Regulation, Leukemic, B-Cell, Hematology, Biological Sciences, DNA Methylation, His, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphocytic, Transfer, Small Untranslated, Gene Expression Regulation, Case-Control Studies, RNA, RNA, Small Untranslated, tRNA fragments
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).54 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!